Dexmedetomidine versus ketamine by administration as nasal spray for sedation in children undergoing spine surgery
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/04/042249
- Lead Sponsor
- Ankur Luthra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 64
Inclusion Criteria
64 ASA I and II children aged between 1-10years scheduled for spinal dysraphism surgery will be enrolled in this study.
Exclusion Criteria
Refusal of consent
Known allergy to dexmedetomidine or ketamine
ASA III or IV
Children with cardiac anomalies
Children with seizures
Children with upper respiratory tract infection
Children with liver disease
Children with mental retardation
Difficult cannulation (three or more attempts)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method